Search

everythinglearnresearchcommunity

for

Search:↓

A hand-held dermatoscope helped differentiate between pressure-induced alopecia and alopecia areata in a young patient, who then experienced hair regrowth within a month.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Platelet rich plasma is an effective treatment for alopecia areata.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Upadacitinib may effectively treat alopecia areata without side effects.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata treatment varies, with no optimal method established yet.

FFA's causes may include environmental triggers and genetic factors.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New alopecia treatments aim for better results and fewer side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.